Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News United Therapeutics Corp UTHR

Healthcare Biotechnology
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more

Recent & Breaking News (NDAQ:UTHR)

Pre-Market Analysis on STSI, IPXL, PCYC, and UTHR

Accesswire May 21, 2013

United Therapeutics Corporation Reports First Quarter 2013 Financial Results

PR Newswire April 25, 2013

United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013

PR Newswire April 18, 2013

StockCall Scrutinizes Warner Chilcott, Dynavax Technologies, Isis Pharma, and United Therapeutics

PR Newswire April 11, 2013

Warner Chilcott, Dynavax Technologies, Isis Pharma, United Therapeutics, and Pharmacyclics Under StockCall's Microscope

PR Newswire March 13, 2013

United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results

PR Newswire February 26, 2013

United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013

PR Newswire February 19, 2013

Free Research Reports on NSPH, STZ, and UTHR Issued by the Bedford Report

Marketwired February 15, 2013

Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High

Marketwired February 15, 2013

Free Research Report on United Therapeutics Corp., Embraer S.A., Charles River Laboratories International, Inc., PolyOne Corp. and Telefonica Brasil, S.A.

Marketwired February 15, 2013

United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA

PR Newswire February 14, 2013

United Therapeutics Announces Additional $420 Million Share Repurchase Program

PR Newswire February 4, 2013

Should Recent Insider Buying on MNKD, TCB, UTHR Matter to You?

Marketwired December 26, 2012